title: Effect of preterm formula with and without long-chain polyunsaturated fatty acids on the urinary excretion of F2-isoprostanes and 8-epi-prostaglandin F2alpha.
abstract: BACKGROUND
  The objective of this study was to evaluate the effect of conventional and long-chain polyunsaturated fatty acids (LCP)-enriched preterm formula on the endogenous formation of F2-isoprostanes and 8-epi-prostaglandin (PG) F2alpha as possible markers of lipid peroxidation in preterm infants during their first weeks of life.
  
  
  METHODS
  In a prospective, randomized, double-blind study, infants received either formula enriched with LCP (n = 8), standard preterm formula (n = 7), or (expressed) breast milk (n = 8). Urine was sampled at study entry and after the study period of 3 weeks. The formation of F2-isoprostanes and 8-epi-PGF2alpha was evaluated by measuring the urinary excretion by gas chromatography-mass spectrometry.
  
  
  RESULTS
  No differences in the urinary excretion of F2-isoprostanes and 8-epi-PGF2alpha were observed at the end of the study period.
  
  
  CONCLUSIONS
  This result suggests that supplementation of a preterm formula with LCP for a period of 3 weeks does not stimulate lipid peroxidation in preterm infants.
authors.affiliation: Department of Pediatrics, Philipps University, Marburg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Stier
authors.forename: H
authors.initials: H
authors.lastname: Schweer
authors.forename: J
authors.initials: J
authors.lastname: Jelinek
authors.forename: B
authors.initials: B
authors.lastname: Watzer
authors.forename: H W
authors.initials: HW
authors.lastname: Seyberth
authors.forename: A
authors.initials: A
authors.lastname: Leonhardt
mesh_terms: D015237:Dinoprost / Q000031:analogs & derivatives / Q000096:biosynthesis / Q000652:urine*; D028441:F2-Isoprostanes; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000494:pharmacology*; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D006801:Humans; D007225:Infant Food; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature; D015227:Lipid Peroxidation / Q000187:drug effects*; D008895:Milk, Human; D011446:Prospective Studies
chemical_list: D028441:F2-Isoprostanes; D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost